HRX215, White opaque capsules, size 1 clinical trials

Double-blind, randomized, placebo-controlled, study to evaluate the safety and efficacy of HRX215 in participants after major hepatectomy, preceded by two open pilot parts in participants after minor and after major hepatectomy due to colon carcinoma metastases

This study is testing a new medicine, HRX215, for people who have had surgery for bowel cancer that has spread to their liver. It looks at how safe the medicine is and if it works to help the liver recover after surgery, using a comparison to a dummy medicine.